Bluejay Price To Sales Ratio from 2010 to 2024
| BJDX Stock | USD 0.58 0.01 1.75% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 27.69 | Current Value 24.62 | Quarterly Volatility 1.72348855 |
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Selling General Administrative of 2.7 M, as well as many exotic indicators such as Price To Sales Ratio of 24.62, Dividend Yield of 0.0 or PTB Ratio of 0.49. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
Bluejay | Price To Sales Ratio |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bluejay Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bluejay Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bluejay Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bluejay Diagnostics Stock:Check out the analysis of Bluejay Diagnostics Correlation against competitors. For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.Note that the Bluejay Diagnostics information on this page should be used as a complementary analysis to other Bluejay Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Bluejay Stock analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Bluejay Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluejay Diagnostics. If investors know Bluejay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluejay Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.08) | Return On Assets (0.79) | Return On Equity (1.55) |
The market value of Bluejay Diagnostics is measured differently than its book value, which is the value of Bluejay that is recorded on the company's balance sheet. Investors also form their own opinion of Bluejay Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Bluejay Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluejay Diagnostics' market value can be influenced by many factors that don't directly affect Bluejay Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluejay Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluejay Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluejay Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.